1.34 USD
▲+0.06+4.69%
盘后 1.24 -3.23%
2026-08-03
市值
$20.07M
市盈率
—
EPS
-0.95
股息率
—
52 周区间
1.13 – 3.78
成交量
133.81K
Beta
1.02
目标价
9.67
52W 低 1.1352W 高 3.78
价格走势
公司简介
Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor sympto...